Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
The aim of the Primary Care Cardiovascular Society (PCCS) is to provide activities which benefit the community of healthcare practitioners who deliver care to people with, or at risk of, cardiovascular disease. We support, educate and mentor healthcare practitioners to develop their knowledge and skills. We offer a programme of educational events throughout the year as well as offering our… View more
Author(s): Navin K Kapur Added: 2 months ago
ACC.26 – Dr Navin Kapur (Tufts Medicine, Boston, MA, US) joins us to discuss findings from the STEMI-Door To Unload (DTU) randomised clinical trial, examining whether primary left ventricular unloading with the Impella CP® device prior to reperfusion can reduce infarct size and heart failure-related outcomes in patients presenting with anterior ST-elevation myocardial infarction.This prospective,… View more
Author(s): Guillaume Baudry Added: 1 month ago
HFA Congress 2026 — Dr Guillaume Baudry (University Hospital of Brabois, Nancy, FR) joins us to discuss findings from the UF-CARE trial, evaluating ultrafiltration against enhanced medical therapy in patients with type 2 cardiorenal syndrome.This randomised, open-label study enrolled patients with severe, refractory heart failure and concurrent chronic kidney disease, a population with a high… View more
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 6 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more
Author(s): Added: 1 week ago
Prof Isabella Kardys (Erasmus MC University Medical Center, Rotterdam, NL) joins us to discuss how proteomic phenotyping, serial biomarkers and digital monitoring could enable more personalised, proactive heart failure care.Prof Kardys outlines work applying large-scale proteomics to HFpEF, where serial profiling of around 5,000 proteins in over 400 patients has revealed distinct subphenotypes… View more
Author(s): Ahmad Masri , Added: 2 years ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive… View more
Author(s): Lin Yee Chen Added: 1 week ago
Dr Lin Yee Chen (University of Minnesota Medical School, Minneapolis, MN, US) joins us to examine which artificial intelligence (AI) applications in heart failure are ready for clinical use today, and which remain experimental. As AI moves from research settings into the clinic, separating genuine clinical utility from hype has become a pressing question for heart failure specialists.In this… View more